Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma

Table 1

Prediction of potential of small molecule drugs in UCS.

Cmap name	Mean	Enrichment
Chlorhexidine	-0.32	-0.72	0.00372
Trimethoprim	0.367	0.695	0.00653
Imatinib	0.452	0.941	0.00658
Diethylstilbestrol	-0.33	-0.606	0.01273
Ciclopirox	0.48	0.706	0.0153
PF-01378883-00	0.435	0.698	0.01719
11-Deoxy-16,16-dimethylprostaglandin E2	0.318	0.683	0.0217
Ramipril	0.372	0.669	0.02656
Trolox C	0.148	0.643	0.03937
Alpha-yohimbine	-0.419	-0.721	0.04479